Bevacizumab does not increase risk of perforation in patients undergoing percutaneous endoscopic gastrostomy or jejunostomy placement Meeting Abstract


Authors: Dibba, P.; Schattner, M. A.; Mendelsohn, R.
Abstract Title: Bevacizumab does not increase risk of perforation in patients undergoing percutaneous endoscopic gastrostomy or jejunostomy placement
Meeting Title: 2019 American Society for Gastrointestinal Endoscopy (ASGE) Digestive Disease Week (DDW)
Keywords: gastrointestinal perforation
Journal Title: Gastrointestinal Endoscopy
Volume: 89
Issue: 6 Suppl.
Meeting Dates: 2019 May 18-21
Meeting Location: San Diego, CA
ISSN: 0016-5107
Publisher: Mosby Elsevier  
Date Published: 2019-06-01
Start Page: AB486
Language: English
ACCESSION: WOS:000470094902196
DOI: 10.1016/j.gie.2019.03.793
PROVIDER: wos
Notes: Meeting Abstract: Mo1314 -- Source: Wos
Altmetric
Citation Impact
MSK Authors
  1. Mark Schattner
    114 Schattner
  2. Pratima Dibba
    1 Dibba